Hyperlipidemia
Conditions
Interventions
Simvastatin treatment group:Simvastatin
placebo:Fumigation with placebo
Fumigation with LSJZ:Fumigation with Lishi Jiangzhi (reducing lipids) decoction
Sponsors
Guanganmen Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Male or female who meets research diagnostic criteria for hyperlipidemia: TC more than 6.22 mmol/L or TG more than 2.26 mmol/L or LDL-C more than 4.14mmol/L or HDL-C less than 1.04 mmol/L; 2. Being up to diagnostic criteria of phlegm-damp and blood stasis syndrome in TCM; 3. Range in age from 30 to 70; 4. Voluntarily signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. The patient has suffered acute myocardial infarction, cerebral vascular accident, severe trauma or big reforms within six months. Or the patient who has high blood pressure don't have it under control(higher than 180/110 mmHg); 2. Hyperlipidemia due to nephritic syndrome, hypothyroidism, gout, acute or chronic hepatobiliary diseases, diabetes and so on; 3. Hyperlipidemia is caused by the use of drugs, familial hypercholesterolemia and TG more than 11.3 mmol/L; 4. The patient is using heparin, thyroid hormone or other drugs which can cause metabolic disorder of serum lipids. Or the patient is using other lipid-lowering agents within 2 weeks; 5. The patient has severe vital primary disease of liver, kidney, hematopoietic system and other systems, or a psychopath.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cholesterol;Triglycerides;Low-density lipoprotein;High-density lipoprotein; | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight;TCM symptoms;tongue picture;pulse;blood pressure; | — |
Countries
China
Contacts
Public ContactLING FENG
Outcome results
None listed